{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:08:40Z","timestamp":1785276520552,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.dld.2014.08.040","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T07:57:39Z","timestamp":1410854259000},"page":"1116-1120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: A retrospective cohort study"],"prefix":"10.1016","volume":"46","author":[{"given":"Anna","family":"Licata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Maida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cabibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Butera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio S.","family":"Macaluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Alessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calogero","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Crax\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero L.","family":"Almasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2014.08.040_bib0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.08.040_bib0010","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2014.08.040_bib0015","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.dld.2014.08.040_bib0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2796.2007.01818.x","article-title":"Acute liver failure in Sweden: etiology and outcome","volume":"262","author":"Wei","year":"2007","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.dld.2014.08.040_bib0025","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bj\u00f6rnsson","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.08.040_bib0030","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/ard.2004.032821","article-title":"Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis","volume":"64","author":"Germano","year":"2005","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.dld.2014.08.040_bib0035","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00042737-200505000-00019","article-title":"Rosuvastatin-associated hepatitis with autoimmune features","volume":"17","author":"Wolters","year":"2005","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2014.08.040_bib0040","first-page":"703","article-title":"Autoimmune hepatitis triggered by administration of an herbal medicine","volume":"92","author":"Kamiyama","year":"1997","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.08.040_bib0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11739-012-0777-x","article-title":"Herbal hepatotoxicity: a hidden epidemic","volume":"8","author":"Licata","year":"2013","journal-title":"Internal and Emergency Medicine"},{"key":"10.1016\/j.dld.2014.08.040_bib0050","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug-induced autoimmune-like hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.dld.2014.08.040_bib0055","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.23696","article-title":"Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop","volume":"52","author":"Fontana","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.08.040_bib0060","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal Gp","year":"2011","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2014.08.040_bib0065","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2011.02.024","article-title":"Drug-induced liver injury and its relationship between to autoimmune hepatitis","volume":"55","author":"Weiler Normann","year":"2011","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2014.08.040_bib0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.08.040_bib0075","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2014.04.045","article-title":"Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C","volume":"61","author":"Macaluso","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2014.08.040_bib0080","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/gut.2010.228478","article-title":"Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis","volume":"60","author":"Di Marco","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.dld.2014.08.040_bib0085","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jhep.2010.12.041","article-title":"Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish registry: the dilemma of the relationship with autoimmune hepatitis","volume":"55","author":"Lucena","year":"2011","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2014.08.040_bib0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1440-1746.2003.02918.x","article-title":"Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type I in Chinese patients","volume":"18","author":"Qiu","year":"2003","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2014.08.040_bib0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0198-8859(00)00234-2","article-title":"Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus","volume":"62","author":"Goldberg","year":"2001","journal-title":"Human Immunology"},{"key":"10.1016\/j.dld.2014.08.040_bib0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.autrev.2010.09.024","article-title":"Autoimmune hepatitis, HLA and extended haplotypes","volume":"10","author":"Oliveira","year":"2011","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.dld.2014.08.040_bib0105","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles","volume":"141","author":"Lucena","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2014.08.040_bib0110","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jhep.2010.05.033","article-title":"Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury","volume":"53","author":"Donaldson","year":"2010","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2014.08.040_bib0115","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nature Genetics"},{"key":"10.1016\/j.dld.2014.08.040_bib0120","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2014.08.040_bib0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","article-title":"Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission","volume":"58","author":"vanGerven","year":"2013","journal-title":"Journal of Hepatology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865814006604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865814006604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T15:26:13Z","timestamp":1538234773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865814006604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1590865814006604"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2014.08.040","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2014.08.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}